Agents that produce neuromuscular block (indirect)

DBCAT003930Pharmacologic class

In this category, it is included all agents that induce neuromuscular block as a secondary effect or side effect. A DrugBank category of 72 drugs. 56 of them are approved.

Also known as: Agents that produce neuromuscular block
Drugs: Apramycin
Arbekacin
Bekanamycin
Botulinum toxin type A
Botulinum toxin type B
Capreomycin
Chloroquine
Chlortetracycline
Clindamycin
Clomocycline
Colistimethate
Colistin
Cyclosporine
Dantrolene
Demeclocycline
Dibekacin
Dihydrostreptomycin
Doxycycline
Etacrynic acid
Framycetin
Geneticin
Gentamicin
Gentamicin C1a
Hygromycin B
Isepamicin
and 47 more with a free account

What you can answer from here — as of December 24, 2018

72DrugsEach linked to its full drug card

133Drug targetsEvery drug–target pair in the class, with bond type

13,754Marketed productsAcross the regions we cover, with dosage forms and routes

41Routes of administrationHow the drugs in this class are given

Which targets do Agents that produce neuromuscular block (indirect) share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account